PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases
author
Lankin, Vadim Z.
Tikhaze, Alla K.
Viigimaa, Margus
Chazova, Irina Evgenevna
statement of authorship
V.Z. Lankin, A.K. Tikhaze, M. Viigimaa, I.E. Chazova
source
Terapevticheskii Arkhiv
publisher
CJSC Consilium Medicum
journal volume number month
Vol. 90, 9
year of publication
2018
pages
p. 27-30
url
https://doi.org/10.26442/terarkh201890927-30
subject term
antioksüdandid
ensüümid
kolesterool
ravimid
inhibiitorid
lipoproteiinid
keyword
antioxidant enzymes
cholesterol-lowering drugs
inhibitor of PCSK9
oxidized low-density lipoproteins
ISSN
0040-3660
notes
Bibliogr.: 15 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
1.1
Scopus
Journal metrics at Scopus
Article at Scopus
WOS
Journal metrics at WOS
Article at WOS
category (general)
Arts and humanities
en
Kunst ja humanitaarteadused
et
Medicine
en
Meditsiin
et
category (sub)
Arts and humanities. History
en
Kunst ja humanitaarteadused. Ajalugu
et
Medicine. Family practice
en
Meditsiin. Perepraktika
et
Medicine. Internal medicine
en
Meditsiin. Sisehaigused
et
kvartiil
Q4
TTÜ department
tervisetehnoloogiate instituut
language
inglise